This study examined the relative impact of pain relief and opioid side effects on patients' and
physicians' preferences for medication. An Internet survey was completed by 618 patients (…

In the 21 years since social capital first appeared in the public health literature, the evidence
base has grown enormously, now reaching 28 systematic reviews encompassing more than …

Placebo data were pooled from two 1-year, randomized, double-blind, placebo-controlled
trials of sabeluzole in patients with mild-to-moderate Alzheimer disease (AD). Cognition was …

The objective of this study is to evaluate the incidence and cost of needlestick injuries (NIs)
in the United States, United Kingdom, Germany, France, Italy, and Spain. Comprehensive …

Background Active Support, now widely adopted by disability support organizations, is
difficult to implement. The study aim was to identify the factors associated with good Active …

Public health agencies tasked with improving the health of communities are poorly supported
by many ‘business-as-usual’ funding practices. It is commonplace to call for more funding …

Objective This study evaluated patient and treatment (galantamine and other acetylcholinesterase
inhibitors (AChEIs)) factors associated with the time until nursing home placement (…

Background The mechanisms typically used to fund health promotion in communities, either
as part of an effort to scale-up programs or to support the design of local activities, often pay …

Background Gastrointestinal (GI) adverse effects are common with oral opioid treatment.
Objective To estimate the costs associated with GI events after oral short-acting opioid treatment…

Background: Galantamine (hydrobromide), a reversible acetylcholinesterase inhibitor and
allosteric nicotinic receptor modulator, slows cognitive and functional decline in mild to …